1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Winner Medical Co., Ltd.

Winner Medical Co., Ltd.

300888.SZ
Winner Medical Co., Ltd.CN flagShenzhen Stock Exchange
28.19
CNY
+0.16
- -
16.43BMarket Cap
Winner Medical Co., Ltd.
300888.SZ
(Shenzhen Stock Exchange)

Recent

price

28.19

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
3.54
4.95
6.78
7.36
8.67
23.03
13.48
19.19
13.82
15.36
18.82
17.72
Revenue per Share
- -
- -
0.43
0.79
0.83
0.81
1.04
7
2.08
2.79
0.98
1.19
1.32
1.39
Basic EPS, GAAP
- -
- -
-0.52
-0.56
-0.33
-0.33
0.29
7.71
0.22
3.02
0.52
0.62
1.75
-1.33
Free Cash Flow per Basic Share
- -
- -
0.12
0.11
0.22
0.11
0.11
0.19
1.29
0.68
1.39
0.71
1.04
0.93
Dividend per Share
- -
- -
1.22
1.86
2.45
3.12
3.97
10.09
10
12.26
12.16
12.6
13.27
13.34
Book Value per Share
- -
- -
2.4
3.05
3.58
4.85
5.75
18.74
17.48
17.1
17.31
16.31
17.57
17.26
Tangible Book Value per Share
- -
- -
515
517
516
522
527
544
596
592
592
584
582
578
Basic Weighted Avg Shares
1,272
1,510
1,819
2,560
3,498
3,839
4,575
12,534
8,037
11,351
8,185
8,978
10,949
10,241
Sales/Revenue/Turnover
9.33
11.73
14.87
19.68
16.09
13.9
13.93
39.84
16.23
19.32
11.47
10.85
11.93
11.6
Operating Margin (%)
- -
- -
- -
- -
80
94
103
159
377
482
540
578
663
- -
Depreciation Expense
88
129
221
410
427
425
546
3,810
1,239
1,651
580
695
768
803
Net Income, GAAP
12.06
16.6
16.16
18.28
17.28
14.98
14.29
15.1
15.4
12.77
16.18
18.46
22.3
21.09
Effective Tax Rate (%)
6.93
8.55
12.12
16
12.21
11.06
11.94
30.4
15.42
14.54
7.09
7.75
7.01
7.84
Profit Margin (%)
193
533
485
570
366
683
1,487
8,363
8,271
6,638
6,285
2,810
3,597
3,104
Working Capital
- -
- -
- -
- -
- -
5
134
364
382
326
462
494
467
463
LT Debt
742
1,142
1,310
1,653
1,978
2,661
3,164
10,408
10,687
12,198
12,110
11,876
12,293
12,276
Total Equity
- -
12.96
17.08
26.41
22.55
16.92
17.02
56.72
9.65
14.36
5.32
5.46
6.83
6.52
Return on Invested Capital (%)
- -
25.56
34.36
48.91
33.21
25.03
26.42
88.62
19.8
19.49
5.7
6.65
6.97
7.77
Return on Capital (%)
- -
35.99
42.52
51.63
38.46
29.43
29.38
100.44
21.63
24.98
8.03
9.55
10.18
10.71
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
2,366
2,003
2,007
LT Borrowings
53
53
50
LT Finance Leases
441
409
413
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
582
582
582
Market Capitalization
24,763
26,625
23,758

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
8,081
7,494
7,644
Cash, Cash Equivalents & STI
4,333
3,533
3,657
Accounts Receivable, Net
981
1,120
1,205
Inventories
1,958
1,958
1,946
Total Current Liabilities
5,272
4,421
4,540
Payables & Accruals
- -
- -
- -
ST Debt
2,366
2,003
2,007
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
34.59%
3.53%
3.51%
Free Cash Flow
372.65%
261.25%
178.94%
Net Income, GAAP
64.67%
-13.77%
10.44%
Sales/Revenue/Turnover
28.94%
1.82%
21.96%
Total Cash Common Dividend
82.92%
141.01%
47.05%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,909
2,124
2,037
2,908
8,978
2025
2,605
2,691
3,052
- -
10,949
2026
2,679
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.31
- -
- -
- -
1.19
2025
0.43
- -
- -
- -
1.32
2026
0.43
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.71
2025
0.11
- -
- -
- -
1.04
2026
0.01
- -
- -
- -
- -
Similar Companies
Kossan Rubber Industries Bhd (KSRBF)
Guangzhou Jet Bio-Filtration Co., Ltd. (688026.SS)
QuidelOrtho Corporation (QDEL)
SheerVision, Inc. (SVSO)
Innovative MedTech Inc. (IMTH)
Airway Medix S.A. (AWM.WA)
Business
Winner Medical Co., Ltd. (300888.SZ) manufactures and markets disposable medical consumables, wound care products, operating room solutions, and consumer health goods centered on cotton-based technologies in China and internationally. The company produces wound care items including traditional dressings such as gauze swabs, lap sponges, and bandages; advanced solutions like foam dressings, silicone foam dressings, super absorbent pads, collagen dressings, antimicrobial products, scar repair treatments, and compression therapies; as well as liquid skin protectants, debridement aids, and exudate management products; operating room supplies encompassing masks, gloves, protective apparel, surgical gowns and drapes, specialty packs, general surgical kits and trays, disinfection products, anesthesia kits, and catheter sets; and consumer offerings such as adult diapers, incontinence pads, cotton balls and swabs, foot care products, hand sanitizers, facial and lens cleansing wipes, sports hygiene items, wet and dry cotton towels, sanitary napkins, baby clothing, and cosmetic cotton products, marketed under the Winner Medical, Purcotton, and PureH2B brands for hospitals, pharmacies, personal protective equipment users, consumers, and industrial applications. Winner Medical operates production facilities in China, with products sold in multiple countries, and maintains a subsidiary relationship with Winner Group Limited. Founded in 1991 and headquartered in Shenzhen's Longhua District, the company listed on the Shenzhen Stock Exchange's A-share market in September 2020. In September 2024, Winner Medical completed its first international equity acquisition by purchasing a 75.2% stake in U.S.-based Global Resources International Inc. (GRI) for approximately $120 million, enhancing its global supply chain resilience, expanding product lines in surgical kits, drapes, gowns, and industrial protective clothing, and establishing operations in the United States and Europe.